Baxter revealed its plans to split itself into two separate and independent entities, while Cefaly Technology obtained FDA clearance for its device for preventative treatment of migraine headaches. Medicaldevice-network.com wraps-up the key headlines from March 2014.
Thermo Fisher Scientific completed its acquisition of Life Technologies, a life sciences company, for approximately $13.6bn, while Medtronic reported the first implant of vitamin-sized leadless pacemaker in US. Medicaldevice-network.com wraps-up the key headlines from February 2014.
The Carlyle Group agreed to buy Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business for $4.15bn, while Edwards Lifesciences obtained CE Mark approval for Sapien 3 transcatheter aortic valve. Medicaldevice-network.com wraps-up the key headlines from January 2014.